Oncology and Hematology

Oncology and Hematology Clinical Practice

Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.

Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.

Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.

977

LikeLikedUnlike

16-30 of 298

MinuteCE®
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
- Barbara O'Brien, MD
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
- Nadia Harbeck, MD, PhD
1.00 credits 6 episodes
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
MinuteCE®
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
- Barbara O'Brien, MD
- Nadia Harbeck, MD, PhD
1.00 program credits
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credits
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
MinuteCE®
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credits
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
MinuteCE®
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
- Barbara O'Brien, MD
- Nadia Harbeck, MD, PhD
1.00 program credits
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CE
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
- Mukul Sharma, MD, MSc, FRCPC
- Ashkan Shoamanesh, MD, MSc, FRCPC
0.75 credits
advertisement
Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents
CME/CE
Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents
- Guy Young, MD
- Annette von Drygalski, MD, PharmD, RMSK
- Steven Pipe, MD
- Robert Sidonio Jr, MD, MSc
1.00 credits
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CE
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
- Cem Akin, MD, PhD
0.25 credits
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CE
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
- Harry Erba, MD, PhD
1.00 credits
The Future of HNSCC: Aligning Teams, Transforming Care
CME/CE
The Future of HNSCC: Aligning Teams, Transforming Care
- Ravindra Uppaluri, MD, PhD
- Nancy Lee, MD, FASTRO
0.25 credits
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
- Mariana C. Castells, MD, PhD
- Tsewang Tashi, MD
0.25 credits
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
- Benjamin Levy, MD
0.25 credits
advertisement
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
CME/CE
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
- Taofeek K. Owonikoko, MD, PhD
0.25 credits
Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
CME/CE
Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
- María-Victoria Mateos, MD, PhD
0.25 credits
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
CME/CE
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
- Cristina Rodriguez, MD
0.50 credits